Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma post-surgery.

Authors:
Li C; Yu P; Li H; Yang X; Wang J and 1 more

Journal:
J Cardiothorac Surg

Publication Year: 2024

DOI:
10.1186/s13019-024-02500-9

PMCID:
PMC10811942

PMID:
38273405

Journal Information

Full Title: J Cardiothorac Surg

Abbreviation: J Cardiothorac Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalThe study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by institutional/regional/national ethics/committee/ethics board of The First People’s Hospital of Chang-Zhou City, The Third Affiliated Hospital,Soochow University (2023005) and individual consent for this retrospective analysis was waived. Additional statementsAll authors agree to participate and publish. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by Beijing Xisike Clinical Oncology Rresearch Foundation [Y-HH202101-0117.]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025